Tags: Anxiety | abilify | generic | antipsychotic | drug

Generic Version of Antipsychotic Drug

Tuesday, 28 Apr 2015 04:26 PM

The U.S. Food and Drug Administration said it approved the first copycat versions of Otsuka Pharmaceutical's antipsychotic drug, Abilify.

The FDA said it had granted approval for generic versions of Abilify from four companies, including Teva Pharmaceutical Industries Ltd, to treat mental illnesses such as bipolar disorder and schizophrenia.

Abilify has an orphan drug designation for the treatment of Tourette's syndrome, a nervous system disorder, in children.

The drug, which is also approved to treat schizophrenia and bipolar disorder, went off patent protection for these indications this month.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
FDA-Approved-Drugs
The U.S. Food and Drug Administration said it approved the first copycat versions of Otsuka Pharmaceutical's antipsychotic drug, Abilify. The FDA said it had granted approval for generic versions of Abilify from four companies, including Teva Pharmaceutical Industries Ltd,...
abilify, generic, antipsychotic, drug
88
2015-26-28
Tuesday, 28 Apr 2015 04:26 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved